This article was originally published in The Tan Sheet
Dietary supplements purporting to cure diseases ranging from Alzheimer's to bird flu are the topic of three warning letters sent by FDA in January. In the letters, FDA addresses claims for Long Life Catalog Company's supplement Zap-V, Robert Davis' All-Natural Interferon and Trim International's TCR Cell Rejuvenator. Specifically, FDA takes issue with Zap-V's claims that the product reduces inflammation and acts as an "anticancer, anti-tumor, antiviral" medication, according to the Jan. 30 letter. In Jan. 24 correspondence, the agency targets claims made to promote All-Natural Interferon as "an immune system booster." Finally, in a Jan. 9 letter, the agency addresses claims that TCR Cell Rejuvenator "helps prevent recurrent herpes, common cold and flu, and is used to treat patients with Alzheimer's, Parkinson's, cancer and other infectious diseases and neurological disorders." All the claims are found on the individual products' web sites, according to FDA...
You may also be interested in...
Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.
Broader than initially reported, Merck & Co.’s agreement with BARDA extends beyond J&J’s recently authorized vaccine to other COVID-19 vaccines and therapeutics as needed.
White House, Democrat majority in Congress and likely next FTC chair support the agency wielding the authority, says advertising law attorney Holly Melton. Supreme Court, though, likely will rule in pending cases that a strict reading of an FTC regulation doesn’t grant monetary penalty authority.